Order Total (1 Item Items):
Shipping Destination:
Scott Dessain (51 results)
Skip to main search results
Search filters
Product Type
- All Product Types
- Books (51)
- Magazines & Periodicals (No further results match this refinement)
- Comics (No further results match this refinement)
- Sheet Music (No further results match this refinement)
- Art, Prints & Posters (No further results match this refinement)
- Photographs (No further results match this refinement)
- Maps (No further results match this refinement)
- Manuscripts & Paper Collectibles (No further results match this refinement)
Condition Learn more
- New (43)
- As New, Fine or Near Fine (5)
- Very Good or Good (2)
- Fair or Poor (No further results match this refinement)
- As Described (1)
Binding
Collectible Attributes
- First Edition (1)
- Signed (No further results match this refinement)
- Dust Jacket (No further results match this refinement)
- Seller-Supplied Images (14)
- Not Print on Demand (36)
Language (1)
Free Shipping
Seller Location
Seller Rating
-
Condition: like_new. Fast Free Shipping â" Excellent condition book with clean cover and pages. Barely handled, with minimal wear. An outstanding copy, close to enjoy!
-
Paperback. Condition: Very Good. No Jacket. May have limited writing in cover pages. Pages are unmarked. ~ ThriftBooks: Read More, Spend Less.
-
Human Antibody Therapeutics for Viral Disease
Book 42 of 322: Current Topics in Microbiology and ImmunologyLanguage: English
Published by Springer Berlin / Heidelberg, 2007
ISBN 10: 3540721444 ISBN 13: 9783540721444
First Edition
Condition: Good. 1st Edition. Former library copy. Pages intact with minimal writing/highlighting. The binding may be loose and creased. Dust jackets/supplements are not included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
-
Condition: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.
-
-
Preserving the Promise: Improving the Culture of Biotech Investment
Language: English
Published by Academic Press 2016-10-12, 2016
ISBN 10: 0128092165 ISBN 13: 9780128092163
US$ 44.44
US$ 20.81 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketPaperback. Condition: New.
-
Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
-
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
-
Condition: As New. Unread book in perfect condition.
-
Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
-
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
-
Condition: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.
-
Condition: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.
-
Condition: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed.
-
Preserving the Promise: Improving the Culture of Biotech Investment
Language: English
Published by Elsevier Science Publishing Co Inc, 2016
ISBN 10: 0128092165 ISBN 13: 9780128092163
Seller: THE SAINT BOOKSTORE, Southport, United Kingdom
Seller rating 5 out of 5 stars
US$ 57.81
US$ 20.49 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketPaperback / softback. Condition: New. New copy - Usually dispatched within 4 working days.
-
Preserving the Promise : Improving the Culture of Biotech Investment
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Seller rating 5 out of 5 stars
US$ 59.96
US$ 20.15 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New.
-
Preserving the Promise: Improving the Culture of Biotech Investment
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
US$ 65.04
US$ 16.09 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
Preserving the Promise: Improving the Culture of Biotech Investment
Language: English
Published by Academic Press 2016-10-12, 2016
ISBN 10: 0128092165 ISBN 13: 9780128092163
US$ 61.21
US$ 20.81 shipping
Ships from United Kingdom to U.S.A.Quantity: 10 available
Add to basketPaperback. Condition: New.
-
Preserving the Promise : Improving the Culture of Biotech Investment
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Seller rating 5 out of 5 stars
US$ 71.48
US$ 20.15 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: As New. Unread book in perfect condition.
-
Condition: New. pp. xii + 190 1st Edition.
-
Condition: New. pp. xii + 190.
-
Condition: New. pp. xii + 190.
-
Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
-
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
-
Condition: New.
-
Condition: Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | Although the utility of human antibodies as medical therapeutics for cancer and immune diseases has been well-established, it is only beginning to be realized for the treatment of viral infectious diseases. Polyclonal immunoglobulins have long been used for some viral diseases, but they have limited potency and disease scope. It should theoretically be possible to create monoclonal or oligoclonal antibody preparations that capture the essential curative functions of the humoral immune response to viral pathogens, yet only a single humanized monoclonal antibody (pavilizumab) has been approved as a viral countermeasure. Reliable technologies for creating human or humanized antibodies with defined viral antigen specificities are well-established. Accordingly, current antibody development efforts are focused on identifying and cloning the particular antibodies that contain the fundamental curative potency of the polyclonal humoral immune response.
-
Human Antibody Therapeutics For Viral Disease (Current Topics in Microbiology and Immunology, 317)
Book 42 of 322: Current Topics in Microbiology and ImmunologySeller: Ria Christie Collections, Uxbridge, United Kingdom
Seller rating 5 out of 5 stars
US$ 189.28
US$ 16.09 shipping
Ships from United Kingdom to U.S.A.Quantity: Over 20 available
Add to basketCondition: New. In.
-
Condition: New. pp. xii + 190.
-
Taschenbuch. Condition: Neu. Human Antibody Therapeutics For Viral Disease | Scott K. Dessain | Taschenbuch | Current Topics in Microbiology and Immunology | xii | Englisch | 2010 | Springer | EAN 9783642091315 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu.
-
Human Antibody Therapeutics For Viral Disease
Book 42 of 322: Current Topics in Microbiology and ImmunologyLanguage: English
Published by Springer Berlin Heidelberg, Springer Berlin Heidelberg, 2007
ISBN 10: 3540721444 ISBN 13: 9783540721444
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Although the utility of human antibodies as medical therapeutics for cancer and immune diseases has been well-established, it is only beginning to be realized for the treatment of viral infectious diseases. Polyclonal immunoglobulins have long been used for some viral diseases, but they have limited potency and disease scope. It should theoretically be possible to create monoclonal or oligoclonal antibody preparations that capture the essential curative functions of the humoral immune response to viral pathogens, yet only a single humanized monoclonal antibody (pavilizumab) has been approved as a viral countermeasure. Reliable technologies for creating human or humanized antibodies with defined viral antigen specificities are well-established. Accordingly, current antibody development efforts are focused on identifying and cloning the particular antibodies that contain the fundamental curative potency of the polyclonal humoral immune response.
